Cromolyn sodium in ocular allergic diseases

Area of Science:

• Ophthalmology
• Allergology
• Pharmacology

Background:

• Allergic conjunctivitis encompasses several subtypes, including vernal, giant papillary, ragweed, and atopic forms.
• Type I hypersensitivity reactions are a common cause of ocular allergic symptoms.
• Histamine release plays a critical role in the inflammatory cascade of allergic conjunctivitis.

Purpose of the Study:

• To review the pharmacological action of cromolyn sodium.
• To discuss the therapeutic value of cromolyn sodium in treating type I ocular allergic diseases.

Main Methods:

• Literature review focusing on the mechanism of action of cromolyn sodium.
• Analysis of clinical data and studies pertaining to the efficacy of cromolyn sodium in allergic conjunctivitis.

Main Results:

• Cromolyn sodium functions as a mast cell stabilizer, inhibiting the degranulation and release of histamine.
• This mechanism effectively prevents the inflammatory responses associated with subacute type I hypersensitivity reactions in the eye.
• The drug demonstrates significant efficacy as a topical anti-allergic treatment.

Conclusions:

• Cromolyn sodium is a valuable therapeutic agent for managing various forms of allergic conjunctivitis.
• Its ability to inhibit histamine release makes it a key treatment for type I ocular allergic diseases.
• Topical cromolyn sodium provides an effective anti-allergenic solution for ocular allergy sufferers.